Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Novavax Inc
(NQ:
NVAX
)
4.090
+0.140 (+3.54%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Apr 26, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Novavax Inc
< Previous
1
2
...
8
9
10
11
12
13
14
15
16
...
53
54
Next >
Novavax Jumps After Pledging To Update Its Covid Shot; Pfizer, Moderna Slip
January 27, 2023
The FDA's experts voted in favor of annual boosters on Thursday.
Via
Investor's Business Daily
3 Great Growth Stocks Down 20% or More to Buy Now
January 27, 2023
These beaten-down stocks could be poised for major rebounds.
Via
The Motley Fool
This Investment Strategy Would Have Reduced Your Novavax Losses by 20% Last Year
January 25, 2023
If you want to invest in volatile stocks, a certain strategy can minimize your overall risk.
Via
The Motley Fool
3 Remarkable Stocks That Can Burn Short-Sellers Big-Time in 2023
January 24, 2023
Exceptionally high short interest in these innovative and transformative businesses may lead to a short squeeze.
Via
The Motley Fool
Could Novavax Stock Help You Become a Millionaire?
January 20, 2023
At such a beaten-down valuation, is the upside for Novavax just too significant to ignore?
Via
The Motley Fool
Here's the Worst Mistake Novavax Investors Can Make in 2023
January 20, 2023
Can Novavax still win over the long term?
Via
The Motley Fool
2 Down-on-Their-Luck Stocks That Could Go Parabolic
January 17, 2023
Any bit of good news could send these stocks soaring.
Via
The Motley Fool
With This Big Transition Ahead, Is Novavax a Buy?
January 12, 2023
Novavax stock sank 92% last year.
Via
The Motley Fool
What's Going On With Novavax Stock Today?
January 09, 2023
Novavax Inc (NASDAQ: NVAX) shares are trading higher Monday after the company announced a CEO transition.
Via
Benzinga
River Private Wealth announces new round of investment in Novavax, Inc
January 19, 2023
Via
AB Newswire
3 Biotech Stocks Under $15 Worth a Second Look in 2023
January 18, 2023
All three stocks have promising therapies that could drive revenue in the coming years.
Via
The Motley Fool
Pfizer (PFE) Stock Falls on Analyst Downgrade
January 17, 2023
Although Pfizer led the charge in forwarding Covid-19 solutions, possibly waning relevancy poses serious concerns for PFE stock.
Via
InvestorPlace
If You Invested $1,000 in Novavax In 2020, This Is How Much You Would Have Today
January 13, 2023
The stock has gone on a wild ride over the past few years.
Via
The Motley Fool
Don't Blame the Bear Market for This Growth Stock's Jaw-Dropping Sell-Off
January 12, 2023
Novavax stock would likely have fallen in 2022 even in a bull market.
Via
The Motley Fool
2 Biotechs Making Waves With A Single Product in their Pipeline
January 11, 2023
Catalyst Pharmaceuticals and Harmony Bioscience each have a single product in their respective pipelines, and both show incredible promise.
Via
MarketBeat
HC Wainwright & Co. Maintains Buy Rating for Novavax: Here's What You Need To Know
January 02, 2023
Via
Benzinga
Better Recovery Story Buy: Teladoc vs. Novavax
December 28, 2022
These stocks each sank more than 70% this year.
Via
The Motley Fool
Nasdaq Bear Market: 3 Remarkable Growth Stocks That Can Double Your Money in 18 Months
January 11, 2023
These innovative growth stocks have the tailwinds necessary to deliver triple-digit returns for their shareholders by mid-2024.
Via
The Motley Fool
NVAX Stock Alert: What to Know as Novavax Names New CEO
January 09, 2023
Although a change at the top boosted sentiment for Novavax, the harsh reality is that NVAX stock faces a mountain of worries.
Via
InvestorPlace
Why Is Ocugen (OCGN) Stock Up Today?
January 09, 2023
Ocugen is hoping its Indian-made inactivated Covid-19 shot can provide a low-cost boost for those previously given MRNA-based vaccines.
Via
InvestorPlace
Is Novavax Stock a Bargain After Falling More Than 90% From Its High?
January 05, 2023
Could the biotech be the ultimate contrarian buy of 2023?
Via
The Motley Fool
10 Health Care Stocks Whale Activity In Today's Session
January 04, 2023
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity...
Via
Benzinga
How 'Covid Darling' Pfizer Became A 'Show Me' Story For 2023
January 04, 2023
Sales of Paxlovid and Comirnaty are expected to continue declining this year and next.
Via
Investor's Business Daily
Analyzing Novavax's Short Interest
January 03, 2023
Novavax's (NASDAQ:NVAX) short percent of float has fallen 4.15% since its last report. The company recently reported that it has 24.47 million shares sold short, which is 28.87% of all regular shares...
Via
Benzinga
US Stocks On Track To Start 2023 On Upbeat Note: Investors Shrug Off Past Year's Dismal Show And Pin Hopes On A Rebound
January 03, 2023
Trading in the U.S. index futures suggests that stocks may get off to a strong start in the first trading session of 2023. The mood is in contrast to the cautious outlook given by most Wall Street...
Via
Benzinga
7 Sensational Stocks That Can Double Your Money in 2023
January 03, 2023
Triple-digit returns could be just a click away from the buy button.
Via
The Motley Fool
What You Missed On Wall Street On Friday
December 31, 2022
In the midst of markets falling, some companies had good news, while others took a hit from analysts and a merger is still on hold.
Via
Talk Markets
2 Growth Stocks to Buy Heading Into 2023
December 30, 2022
These biotechs are far from having achieved their full potential.
Via
The Motley Fool
Novavax Kickstarts Phase 2 Trial For COVID-19-Flu Combo, Stand-Alone Flu Vaccine Candidates
December 30, 2022
Via
Benzinga
Why Hoth Therapeutics Shares Are Trading Higher By More Than 130%? Here Are 60 Stocks Moving In Thursday's Mid-Day Session
December 29, 2022
Gainers Hoth Therapeutics, Inc. (NASDAQ: HOTH) shares jumped 131.5% to $10.19 after the FDA accepted the IND application for HT-001.
Via
Benzinga
< Previous
1
2
...
8
9
10
11
12
13
14
15
16
...
53
54
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.